Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 7060
Gene Symbol: THBS4
THBS4
0.010 Biomarker group BEFREE TSP-4 (ng/ml) was measured in 365 PAD patientsusing a commercially available ELISA. 31227875 2020
Entrez Id: 501
Gene Symbol: ALDH7A1
ALDH7A1
0.010 GeneticVariation group BEFREE Cilostazol is a selective inhibitor of phosphodiesterase III (PDE III), which is prescribed for patients with peripheral arterial disease, especially intermittent claudication. 31181990 2020
Entrez Id: 55349
Gene Symbol: CHDH
CHDH
0.010 Biomarker group BEFREE The majority of previous studies investigating intake of marine- and plant-based n-3 PUFA have focused on CHD while other ASCVD such as ischaemic stroke and peripheral artery disease have been less studied. 30982476 2020
Entrez Id: 1847
Gene Symbol: DUSP5
DUSP5
0.010 Biomarker group BEFREE Thus, we have identified a role of DUSP5 in post-ischemic angiogenesis and implicated a DUSP5-ERK-p21 pathway that may serve as a therapeutic target for the modulation of post-ischemic angiogenesis in PAD. 31451089 2019
Entrez Id: 8029
Gene Symbol: CUBN
CUBN
0.010 GeneticVariation group BEFREE The CUBN CC or C-risk-allele of rs1801239 was associated with ESRD (OR 2.04 [1.07-3.87], p = 0.03) and peripheral artery disease (OR 2.08 [1.12-3.88], p = 0.021). 30557881 2019
Entrez Id: 55908
Gene Symbol: ANGPTL8
ANGPTL8
0.010 AlteredExpression group BEFREE Plasma betatrophin levels were also significantly higher in 41 patients with PAD than in 416 without PAD (1354 vs. 981 pg/mL, p<0.001). 30518729 2019
Entrez Id: 6403
Gene Symbol: SELP
SELP
0.010 AlteredExpression group BEFREE The present study aimed to assess the predictive value of the plasma levels of P-selectin (Ps) or endothelin-1 (ET-1) regarding the occurrence of vascular restenosis after endovascular therapy for PAD. 30988775 2019
Entrez Id: 10019
Gene Symbol: SH2B3
SH2B3
0.010 GeneticVariation group BEFREE After Bonferroni correction, we found common variants in SH2B3, ABO, and ZEB2 to be associated with PAD ( P<4.5×10<sup>-5</sup>). 31070467 2019
Entrez Id: 2048
Gene Symbol: EPHB2
EPHB2
0.010 Biomarker group BEFREE Thus, we have identified a role of DUSP5 in post-ischemic angiogenesis and implicated a DUSP5-ERK-p21 pathway that may serve as a therapeutic target for the modulation of post-ischemic angiogenesis in PAD. 31451089 2019
Entrez Id: 23659
Gene Symbol: PLA2G15
PLA2G15
0.010 Biomarker group BEFREE Out of 15,867 patients with NSTE-ACS enrolled in the 6 registries, 2226 (14.0%) had a history of PAD. 30154039 2019
Entrez Id: 10732
Gene Symbol: TCFL5
TCFL5
0.010 GeneticVariation group BEFREE Aggressive risk modification is suggested to reduce the subsequent PAD risk in SA patients with a higher CHADS₂, CHA₂DS₂ASc, or ABCD score. 30764516 2019
Entrez Id: 406949
Gene Symbol: MIR15B
MIR15B
0.010 Biomarker group BEFREE The current study aimed to determine the role of microRNA-15b (miR-15b) in the development of PAD and its associated mechanisms. 31258640 2019
Entrez Id: 4880
Gene Symbol: NPPC
NPPC
0.010 AlteredExpression group BEFREE These studies were complemented by in vivo investigation of neovascularization and vascular remodeling after ischemia or vessel injury, and CNP/NPR-C expression and localization in tissue from patients with peripheral artery disease. 30586761 2019
Entrez Id: 55902
Gene Symbol: ACSS2
ACSS2
0.010 Biomarker group BEFREE Out of 15,867 patients with NSTE-ACS enrolled in the 6 registries, 2226 (14.0%) had a history of PAD. 30154039 2019
Entrez Id: 49
Gene Symbol: ACR
ACR
0.010 Biomarker group BEFREE ACR Appropriateness Criteria<sup>®</sup> Nonatherosclerotic Peripheral Arterial Disease. 31054743 2019
Entrez Id: 9839
Gene Symbol: ZEB2
ZEB2
0.010 Biomarker group BEFREE After Bonferroni correction, we found common variants in SH2B3, ABO, and ZEB2 to be associated with PAD ( P<4.5×10<sup>-5</sup>). 31070467 2019
Entrez Id: 4318
Gene Symbol: MMP9
MMP9
0.010 AlteredExpression group BEFREE In 37 patients with peripheral arterial disease (PAD) (Rutherford Grade III Category 5) who underwent infrapopliteal vein graft and midfoot amputation, plasma levels of fibrinogen, C-reactive protein (CRP), interleukin-1 (IL-1), interleukin-6 (IL-6), tumour necrosis factor-α (TNF-α), and matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) were determined preoperatively and during the follow up. 30773823 2019
Entrez Id: 27335
Gene Symbol: EIF3K
EIF3K
0.010 Biomarker group BEFREE These findings suggest that the beneficial effects of HT are muscle specific and dependent on the treatment temperature in a model of PAD. 31161885 2019
Entrez Id: 4879
Gene Symbol: NPPB
NPPB
0.010 Biomarker group BEFREE Adjusted for age, sex, smoking, body mass index, hypertension, diabetes mellitus and total cholesterol, copeptin (hazard ratio [HR] 1.46; 95% confidence interval [CI] 1.19-1.80), N-BNP (HR 1.28; 95% CI 1.11-1.48), and cystatin C (HR 1.19; 95% CI 1.10-1.29) were independently associated with incident PAD. 31215249 2019
Entrez Id: 6272
Gene Symbol: SORT1
SORT1
0.010 Biomarker group BEFREE We showed that sortilin is significantly and independently associated with the presence of lower limb PAD in a statin-free diabetic population and it may be a promising marker for clinically significant atherosclerosis of the lower limbs. 30634965 2019
Entrez Id: 7412
Gene Symbol: VCAM1
VCAM1
0.010 Biomarker group BEFREE Furthermore, VCAM-1 appeared to be highly discriminative for the detection of PAD (AUC = 0.76; CI 0.67-0.83). 30535754 2019
Entrez Id: 6783
Gene Symbol: SULT1E1
SULT1E1
0.010 Biomarker group BEFREE Conclusion EPLBD+mEST might be safer and more effective than conventional EST alone for stone removal in the presence of PAD. 31718197 2019
Entrez Id: 9994
Gene Symbol: CASP8AP2
CASP8AP2
0.010 Biomarker group BEFREE The purpose of this study was to evaluate the image quality and diagnostic accuracy in the pelvis and abdomen of free-breathing fast low-angle shot-based QISS (FLASH QISS) techniques in comparison to bSSFP QISS in patients with PAD, using computed tomographic angiography as the reference. 31299678 2019
Entrez Id: 5420
Gene Symbol: PODXL
PODXL
0.010 Biomarker group BEFREE Multivariate regression showed that an increase of one standard deviation in s-Podxl was associated with an odds ratio of 3.4 (95% confidence interval = 2.2-4.6, P < 0.001) for the prevalence of PAD. 31097305 2019
Entrez Id: 8600
Gene Symbol: TNFSF11
TNFSF11
0.010 GeneticVariation group BEFREE In ultrasonography-negative cases, TRANCE-MRI detected four additional cases (16%, 4/25) of DVT; three cases (12%, 3/25) of venous compression caused by pelvic lymphadenopathy, hip prosthesis or knee joint effusion; one case (4%, 1/25) of vena cava anomaly; two cases (8%, 2/25) of occult peripheral artery disease (PAD); and one case (4%, 1/25) of an occluded bypass graft. 31847822 2019